COVID-19 Guidance for Clinicians & Opioid Treatment Programs

March 18, 2020 (April 15, 2020)
By Peter Kim

Guidance from the Yale Program in Addiction Medicine

Ready to help?

Support drug policies rooted in social justice, compassion, and evidence. Sign up for our newsletter to get updates and learn how you can take action with us.

Facebook
Twitter

Previous Post
Guidance for People Who Use Substances During COVID-19

Next Post
URGENT APPEAL: Supporting people who use drugs and frontline workers during COVID-19

About Peter Kim

Director of Communications and Digital Engagement, Canadian Drug Policy Coalition

The Canadian Drug Policy Coalition is a partner project with the Centre for Applied Research in Mental Health and Addiction (CARMHA), a research centre based at the Faculty of Health Sciences, Simon Fraser University, Vancouver.

Sign up for latest news and updates

Disclaimer

Twitter
Facebook
Instagram